Cited by 65Mobile Health and mHealth ApplicationsDiabetes Management and ResearchDiabetes Management and Education

Effects of mobile phone application combined with or without self‐monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial

Open access
Yu, Yuan, Yan, Qun, Li, Huizhi, Li, Hongmei, Wang, Lin, Wang, Hua, Zhang, Yiyun, Xu, Lei +6 more·2019·Journal of Diabetes Investigation

Abstract

Aims/Introduction: There is potential for mobile applications to deliver new self‐management interventions for chronic disease, especially in diabetes. The aim of the present study was to evaluate the effects of a mobile phone application (MPA) combined with or without self‐monitoring of blood glucose (SMBG) on glycemic control in patients with diabetes. Materials and Methods: The study was a 24‐week period, four‐arm parallel group, non‐blinded, randomized trial. A total of 185 patients with mean age of 52 years were randomized to group A (no MPA and no SMBG), group B (SMBG only), group C (MPA only) and group D (both MPA and SMBG were used). Changes in glycated hemoglobin (HbA1c), fasting plasma glucose and 1,5‐anhydroglucitol from baseline to week 24 were analyzed. Results: At 24 weeks, the HbA1c levels in patients of all groups decreased significantly from baseline. There were significant differences in the proportions of patients that achieved HbA1c <7% between groups, especially in group C and group D, compared with group A at week 24 (60.4%, 62.2% vs 25.5%, all P < 0.05). 1,5‐Anhydroglucitol changes were obvious in group A and group C at week 24 from baseline (all P < 0.05 within groups). Factorial analysis of anova showed that MPA intervention was the main effective factor for HbA1c change ( F = 4.59, P = 0.034), and there was no effect on HbA1c change for SMBG intervention ( P = 0.975). Conclusions: Implementation of the MPA, Diabetes‐Carer, is effective in improving the proportion of HbA1c <7% in patients with type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdi.13031

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The remaining 4 papers did not specify the type of DM or included a mix of DM types, with 256 patients in the intervention groups and 124 in the control groups.

    “The remaining 4 papers did not specify the type of DM they looked at or included a mix of DM types (256 patients in the intervention groups and 124 patients in the control groups) [66-69].”
  • Yu et al reported on fasting plasma glucose (48 intervention, 47 usual care), but found no significant differences between groups (P>.05).

    “Yu et al [68] reported on fasting plasma glucose (48 patients in the app intervention group and 47 patients in the usual care group), but they found no significant differences between the groups (P>.05).”
  • Yu et al reported a significant difference regarding the proportion of participants reaching the goal of HbA1c ≤7%, with use of the app as the decisive factor (P<.05).

    “The study by Yu et al [68] did not show a significant difference in HbA1c between the groups (P>.05), but a significant difference was reported regarding the proportion of participants reaching the goal of HbA1c ≤7%, with use of the app as the decisive factor (P<.05).”
  • Of the included studies that did not specify the DM type, one found an increase in the proportion of participants with HbA1c <7%.

    “and the other study found an increase in the proportion of participants with HbA1c <7% [68].”
  • Yu et al did not show a significant difference in HbA1c between groups (P>.05).

    “The study by Yu et al [68] did not show a significant difference in HbA1c between the groups (P>.05), but a significant difference was reported regarding the proportion of participants reaching the goal of HbA1c ≤7%, with use of the app as the decisive factor (P<.05).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 26 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Yu, Y., Yan, Q., Li, H., Li, H., Wang, L., Wang, H., Zhang, Y., Xu, L., Tang, Z., Yan, X., Chen, Y., He, H., Chen, J., & Feng, B.
Affiliations
Tongji University (CN)
Corresponding author
Feng, Bo
Venue
Journal of Diabetes Investigation
Publisher
Wiley
Published
2019-03-19
Volume
10
Issue
5
Pages
1365-1371
ISSN
  • 2040-1116 (ISSN-L)
  • 2040-1124
OpenAlex
W2919041142
Cited by
65
References
26
Citations by year
2026: 5 · 2025: 4 · 2024: 15 · 2023: 8 · 2022: 15 · 2021: 8 · 2020: 6 · 2019: 4
FWCI
11.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Investigation (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Key Specialty Construction Project of Pudong Health and Family Planning Commission of Shanghai (PWZz2017-12)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
mobile application, diabetes self-management, self-monitoring of blood glucose, glycemic control, type 2 diabetes, HbA1c, 1,5-anhydroglucitol, digital health interventions
MeSH terms
Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Prognosis, Quality of Life, Blood Glucose Self-Monitoring, Biomarkers, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review